In healthy adults, post-meal GLP-1 release is strongly associated with healthy glucose control and appetite regulation in clinical research
The main risks are a temporary resurgence of GI side effects (nausea, constipation, diarrhea), temporary appetite suppression reduction during the low-dose titration phase, and a short-term weight loss pause as tirzepatide builds toward therapeutic levels
Infect Immun 80(12):4364 Belogolova E, Bauer B, Pompaiah M, Asakura H, Brinkman V, Ertl C, Meyer TF (2013) Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor
Appetite regulation and reduced cravings may begin within the first 13 weeks
Greiner, T
More common but challenging side effects include persistent nausea affecting 44% of users and significant fatigue in 11%